Despite achieving 20.35% year-on-year revenue growth in Q4 FY26, the company's profitability metrics deteriorated sharply across all parameters. The PAT margin contracted drastically to 1.91% from 11.60% in Q4 FY25, whilst the operating margin (excluding other income) compressed to 8.12% from 8.54% a year ago. The sequential quarterly performance was even more troubling, with net sales declining 31.62% from ₹8,779.45 crores in Q3 FY26, reflecting significant seasonal weakness in the fertiliser business during the March quarter.
Quarterly Performance Trend: Deteriorating Profitability Across Metrics
| Quarter | Net Sales (₹ Cr) | QoQ Change | Net Profit (₹ Cr) | QoQ Change | PAT Margin |
|---|---|---|---|---|---|
| Mar'26 | 6,003.66 | -31.62% | 139.93 | -72.34% | 1.91% |
| Dec'25 | 8,779.45 | -9.06% | 505.88 | -37.18% | 5.56% |
| Sep'25 | 9,654.13 | +37.09% | 805.33 | +59.47% | 8.22% |
| Jun'25 | 7,042.30 | +41.17% | 505.01 | -12.88% | 7.12% |
| Mar'25 | 4,988.39 | -28.07% | 579.67 | +13.27% | 11.60% |
| Dec'24 | 6,935.19 | -6.70% | 511.77 | -22.93% | 7.32% |
| Sep'24 | 7,432.83 | — | 664.05 | — | 8.87% |
The quarterly trend table reveals a deeply concerning pattern: whilst Coromandel achieved strong revenue growth on a year-on-year basis, profitability has collapsed quarter after quarter. The PAT margin has contracted from a healthy 11.60% in Q4 FY25 to a meagre 1.91% in Q4 FY26, representing a devastating 969 basis points erosion. This margin compression has been consistent across recent quarters, with PAT margins declining from 8.22% in Q2 FY26 to 5.56% in Q3 FY26 and finally to 1.91% in Q4 FY26.
Financial Performance: Cost Pressures Overwhelm Revenue Growth
For Q4 FY26, Coromandel International reported net sales of ₹6,003.66 crores, marking a 20.35% increase from ₹4,988.39 crores in Q4 FY25. However, this topline growth was entirely negated by escalating costs and a dramatic spike in the tax burden. Operating profit (PBDIT excluding other income) stood at ₹487.78 crores, up from ₹426.01 crores a year ago, but the operating margin contracted to 8.12% from 8.54%, reflecting deteriorating operational efficiency.
The most alarming aspect of Q4 FY26 results was the abnormally high tax rate of 49.64%, which more than doubled from 20.85% in Q4 FY25. This resulted in a tax outgo of ₹113.01 crores on a profit before tax of ₹227.65 crores, leaving minimal residual profit for shareholders. Interest costs also rose 35.53% year-on-year to ₹89.32 crores, whilst depreciation nearly doubled to ₹164.73 crores from ₹85.40 crores, indicating substantial capital expenditure undertaken during the year.
For the full year FY25, Coromandel posted consolidated net sales of ₹24,085 crores, up 9.20% from ₹22,058 crores in FY24. However, net profit grew at a slower pace of 26.47% to ₹2,108 crores from ₹1,667 crores, reflecting gradual margin pressure throughout the year. The company's PAT margin for FY25 stood at 8.80%, up from 7.60% in FY24, but this annual improvement masks the sharp deterioration witnessed in the fourth quarter.
Critical Concern: Unsustainable Tax Rate
The tax rate of 49.64% in Q4 FY26 is highly unusual and unsustainable. This compares to a normalised tax rate of 20.85% in Q4 FY25 and 24.60% for the full year FY25. The abnormally high tax burden in Q4 FY26 has effectively wiped out profitability despite decent operational performance, raising questions about one-time adjustments or deferred tax provisions that may not recur in future quarters.
Operational Challenges: Deteriorating Returns and Rising Leverage
Coromandel's return on equity (ROE) has declined to 17.47% in the latest period from an average of 20.41% over the past five years. Whilst this remains a respectable figure, the downward trajectory is concerning for a company that has historically demonstrated strong capital efficiency. The company's return on capital employed (ROCE) has similarly contracted to 28.74% from a five-year average of 34.52%, indicating reduced profitability on the capital deployed in the business.
The company's balance sheet reveals increasing leverage, with long-term debt rising to ₹85.33 crores in FY25 from zero in previous years. Whilst the absolute debt level remains manageable, the trend is noteworthy given Coromandel's historical position as a net cash company. The debt-to-EBITDA ratio stands at a comfortable 0.28, and the company maintains a net cash position with a net debt-to-equity ratio of -0.23, indicating ample financial flexibility.
Working capital management has been a bright spot, with the company generating strong cash flow from operations of ₹2,463 crores in FY25, up significantly from ₹1,427 crores in FY24. However, this was more than offset by investing activities totalling ₹2,637 crores, primarily driven by capital expenditure programmes. The net result was a cash outflow of ₹871 crores during FY25, reducing the closing cash balance to ₹254 crores from ₹1,126 crores at the end of FY24.
Quality Metrics Remain Strong Despite Recent Weakness
Despite the disappointing Q4 FY26 results, Coromandel's fundamental quality remains intact. The company maintains an "Excellent" quality grade based on long-term financial performance, supported by a five-year sales growth rate of 16.45%, average ROCE of 34.52%, and minimal debt levels. The company's EBIT-to-interest coverage ratio of 14.71 times provides substantial cushion against financial stress, whilst institutional holdings of 31.23% reflect continued confidence from sophisticated investors.
Industry Context: Fertiliser Sector Headwinds
The fertiliser industry in India faces a complex operating environment characterised by government subsidy policies, volatile raw material prices, and seasonal demand patterns. Coromandel's Q4 FY26 results reflect broader industry challenges, including subdued demand during the traditionally weak March quarter and elevated input costs that have compressed margins across the sector.
The company's 20.35% year-on-year revenue growth in Q4 FY26 outpaced the broader fertiliser sector, which declined 4.54% over the past year, demonstrating Coromandel's market share gains despite challenging conditions. However, the inability to translate topline growth into bottom-line expansion raises questions about pricing power and cost management capabilities in the current environment.
Peer Comparison: Premium Valuation Despite Underperformance
| Company | P/E (TTM) | P/BV | ROE (%) | Div Yield (%) | Debt/Equity |
|---|---|---|---|---|---|
| Coromandel Inter | 27.26 | 4.75 | 20.41 | 0.92 | -0.23 |
| Chambal Fert. | 9.52 | 1.85 | 19.28 | 2.20 | -0.08 |
| Deepak Fertilis. | 19.32 | 2.60 | 16.02 | 0.75 | 0.55 |
| EID Parry | 16.13 | 1.74 | 12.82 | — | -0.26 |
| Paradeep Phosph. | 12.86 | 2.06 | 9.84 | 0.61 | 0.67 |
Coromandel International trades at a significant premium to its fertiliser sector peers, with a P/E ratio of 27.26 times compared to the peer group average of approximately 15 times (excluding the outlier FACT). The company's price-to-book ratio of 4.75 times is also substantially higher than peers such as Chambal Fertilisers (1.85x), Deepak Fertilisers (2.60x), and Paradeep Phosphates (2.06x).
This valuation premium is partially justified by Coromandel's superior ROE of 20.41%, which exceeds most peers except FACT. The company also maintains the strongest balance sheet amongst peers with a net cash position (debt-to-equity of -0.23). However, the recent deterioration in quarterly profitability raises questions about whether this premium valuation can be sustained, particularly given that the company's one-year stock return of -15.16% has significantly underperformed the fertiliser sector decline of 4.54%.
Valuation Analysis: Expensive Multiples Amid Deteriorating Fundamentals
At the current market price of ₹1,964.50, Coromandel International trades at a P/E ratio of 27.26 times trailing twelve-month earnings, representing a significant premium to both the fertiliser sector average of 23 times and the broader market. The company's price-to-book ratio of 4.75 times suggests investors are paying nearly five times the book value for each share, a multiple that appears increasingly difficult to justify given the sharp profit decline in Q4 FY26.
The company's valuation grade has been classified as "Very Expensive" since June 2024, reflecting stretched multiples relative to historical norms and peer comparisons. The EV/EBITDA ratio of 17.45 times and EV/EBIT ratio of 20.39 times both suggest limited margin of safety at current levels. The PEG ratio of 0.95, whilst theoretically reasonable, masks the recent sharp deceleration in earnings growth witnessed in Q4 FY26.
Coromandel's dividend yield of 0.92% (based on the latest dividend of ₹9 per share) provides minimal income support to investors, particularly when compared to peers such as Chambal Fertilisers offering 2.20% yield. The company's dividend payout ratio of 21.38% suggests room for increased distributions, but management may choose to conserve cash given the elevated capital expenditure requirements evident in recent quarters.
Shareholding Pattern: Institutional Confidence Waning
| Quarter | Promoter | FII | Mutual Funds | Insurance | Other DII |
|---|---|---|---|---|---|
| Mar'26 | 56.35% | 13.02% | 13.69% | 2.87% | 1.64% |
| Dec'25 | 56.86% | 13.80% | 12.94% | 2.50% | 1.25% |
| Sep'25 | 56.88% | 14.51% | 13.05% | 1.96% | 0.77% |
| Jun'25 | 56.90% | 14.29% | 13.12% | 1.97% | 0.78% |
| Mar'25 | 56.96% | 10.61% | 14.98% | 3.26% | 0.74% |
The shareholding pattern reveals subtle but concerning shifts in institutional sentiment. Promoter holding has declined marginally from 56.96% in March 2025 to 56.35% in March 2026, with a notable 51 basis points reduction in the latest quarter alone. Whilst the absolute promoter holding remains healthy above 56%, the consistent quarterly decline warrants attention.
Foreign institutional investors (FIIs) have reduced their stake from 14.51% in September 2025 to 13.02% in March 2026, indicating weakening conviction amongst international investors. This 149 basis points reduction over two quarters suggests profit-booking or reallocation to more attractive opportunities. Conversely, mutual fund holdings increased from 12.94% to 13.69% during the March 2026 quarter, providing some support, whilst insurance companies raised their stake from 2.50% to 2.87%.
The overall institutional holding of 31.23% remains substantial, but the recent trend of FII selling and promoter stake dilution, combined with disappointing Q4 results, suggests institutional investors may be reassessing their positions. The presence of 630 FII investors and 36 mutual funds indicates broad-based ownership, but this diversification also means significant selling pressure could materialise if sentiment deteriorates further.
Stock Performance: Significant Underperformance Across Timeframes
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | -0.87% | 1.21% | -2.08% |
| 1 Month | -2.16% | 4.33% | -6.49% |
| 3 Months | -13.43% | -6.86% | -6.57% |
| 6 Months | -8.59% | -6.46% | -2.13% |
| YTD | -13.59% | -8.66% | -4.93% |
| 1 Year | -15.16% | -3.59% | -11.57% |
| 2 Years | 63.65% | 5.89% | +57.76% |
| 3 Years | 104.45% | 27.50% | +76.95% |
Coromandel International's stock performance has deteriorated sharply over the past year, with the shares declining 15.16% compared to the Sensex decline of 3.59%, resulting in negative alpha of 11.57 percentage points. The underperformance has been consistent across shorter timeframes, with the stock down 13.43% over three months versus the Sensex decline of 6.86%, and down 2.16% over one month against a Sensex gain of 4.33%.
The stock currently trades at ₹1,964.50, representing a 27.78% correction from its 52-week high of ₹2,720.00 achieved earlier in the year. The shares are also trading below all major moving averages—5-day (₹2,004.05), 20-day (₹2,049.35), 50-day (₹2,061.32), 100-day (₹2,178.50), and 200-day (₹2,239.83)—indicating sustained selling pressure and weak technical momentum.
From a longer-term perspective, the stock has delivered impressive returns, gaining 104.45% over three years and 169.29% over five years, significantly outperforming the Sensex returns of 27.50% and 58.20% respectively. However, this historical outperformance provides little comfort to investors who entered positions during the past year, as the stock has underperformed both the broader market and the fertiliser sector (which declined 4.54% over one year) by a significant margin.
Investment Thesis: Quality Company Facing Cyclical Headwinds
Coromandel International's investment thesis rests on four key pillars: valuation, quality, financial trend, and technical trend. The current assessment reveals a mixed picture with more concerns than positives. The company's valuation remains "Very Expensive" at 27.26 times P/E and 4.75 times P/BV, offering limited margin of safety at current levels. The quality grade of "Excellent" reflects the company's strong long-term fundamentals, including average ROCE of 34.52%, minimal debt, and market leadership position.
However, the financial trend has deteriorated to "Flat" following the disappointing Q4 FY26 results, with net profit declining 75.86% year-on-year despite 20.35% revenue growth. The technical trend is decisively "Bearish," with the stock trading below all moving averages and showing consistent underperformance versus the broader market. The overall Mojo score of 44 out of 100 places the stock in "SELL" territory, down from "HOLD" status earlier.
Key Strengths & Risk Factors
KEY STRENGTHS
- Market Leadership: Largest company in the fertiliser sector with established distribution network and brand recognition
- Strong Historical Returns: Average ROCE of 34.52% and ROE of 20.41% demonstrate superior capital efficiency over the long term
- Minimal Leverage: Net cash position with debt-to-equity of -0.23 provides financial flexibility and cushion against downturns
- Robust Cash Generation: Operating cash flow of ₹2,463 crores in FY25 demonstrates strong underlying business fundamentals
- Institutional Confidence: 31.23% institutional holdings including 630 FII investors reflects continued sophistication investor interest
- Long-term Growth Track Record: Five-year sales CAGR of 16.45% demonstrates consistent market share gains and business expansion
KEY CONCERNS
- Collapsing Profitability: Q4 FY26 net profit declined 75.86% YoY despite 20.35% revenue growth, indicating severe margin pressure
- Abnormal Tax Rate: Tax rate of 49.64% in Q4 FY26 (versus 20.85% in Q4 FY25) raises questions about one-time adjustments or provisions
- Deteriorating Margins: PAT margin contracted to 1.91% from 11.60% YoY, representing a catastrophic 969 basis points erosion
- Rising Interest Costs: Interest expense up 35.53% YoY reflecting higher borrowing costs and working capital requirements
- Expensive Valuation: Trading at 27.26x P/E and 4.75x P/BV offers no margin of safety given deteriorating fundamentals
- Bearish Technical Setup: Stock below all moving averages with consistent underperformance versus market and sector
- Institutional Selling: FII holdings declined 149 bps over two quarters whilst promoter stake reduced by 61 bps over one year
Outlook: What to Watch in Coming Quarters
POSITIVE CATALYSTS
- Normalisation of tax rate to 24-25% range in Q1 FY27 would significantly boost net profit
- Seasonal pickup in fertiliser demand during kharif season (June-September) could drive revenue recovery
- Government subsidy policy clarity and timely payments would improve working capital cycle
- Margin recovery if input cost pressures ease and pricing power improves
- Benefit from capacity expansion investments as new facilities commence operations
RED FLAGS TO MONITOR
- Further deterioration in operating margins below 8% would signal structural profitability challenges
- Continued FII selling and promoter stake reduction indicating weakening confidence
- Inability to pass on cost increases to customers due to competitive or regulatory constraints
- Working capital pressures leading to increased debt levels and interest burden
- Technical breakdown below ₹1,819 (52-week low) would trigger further selling pressure
The key monitoring points for Coromandel International centre on whether the company can restore profitability to normalised levels in the coming quarters. The abnormally high tax rate in Q4 FY26 appears to be a one-time event, and a return to the 24-25% range would significantly improve earnings. However, the underlying margin pressure—evidenced by the 42 basis points contraction in operating margin—suggests more fundamental challenges that may take several quarters to resolve.
Investors should closely watch the Q1 FY27 results (typically announced in July-August) to assess whether the March quarter weakness was seasonal or indicative of deeper structural issues. The kharif season (June-September) is traditionally the strongest period for fertiliser companies, and Coromandel's performance during this period will be critical in determining whether the investment thesis remains intact or requires fundamental reassessment.
The Verdict: Avoid Fresh Positions, Existing Holders Consider Trimming
Score: 44/100
For Fresh Investors: Avoid initiating positions at current levels. The combination of expensive valuation (27.26x P/E), deteriorating quarterly performance (75.86% profit decline), and bearish technical setup creates an unfavourable risk-reward proposition. Wait for meaningful improvement in profitability metrics and technical trend reversal before considering entry. A more attractive entry point would be closer to ₹1,600-1,700 levels, representing 18-20x normalised earnings.
For Existing Holders: Consider reducing exposure on any technical bounce towards ₹2,050-2,100 levels (20-day and 50-day moving averages). Whilst the company's long-term quality remains intact, the sharp deterioration in recent quarterly performance and sustained underperformance versus the market warrant a defensive stance. Investors with strong conviction in the long-term story may hold with a strict 15-20% stop-loss from current levels, but should be prepared for continued near-term volatility.
Fair Value Estimate: ₹1,700-1,800 (13-15% downside from current levels), based on 20-22x normalised FY27 earnings of ₹80-85 per share, assuming tax rate normalisation and modest margin recovery.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results, and all investments carry risk of loss. The views expressed herein are based on information available as of the publication date and are subject to change without notice.
